ArticleCancer cell2011
Cancer biomarkers: closer to delivering on their promise.
Article in Cancer cell, 2011. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
10 citing papers in PubMed, 23 citations in OpenAlex.
- Mendelian randomization study of the relationship between blood and urine biomarkers and lung cancer.Frontiers in oncology · 2024Article
- Multicompartment modeling of protein shedding kinetics during vascularized tumor growth.Scientific reports · 2020Article
- Sequential Nucleophilic "Click" Reactions for Functional Amphiphilic Homopolymers.Polymer chemistry · 2019Article
- Multinozzle emitter array chips for small-volume proteomics.Analytical chemistry · 2013Article
- Molecular biomarkers in glaucoma.Investigative ophthalmology & visual science · 2013Article
- Next-generation proteomics: towards an integrative view of proteome dynamics.Nature reviews. Genetics · 2013Review
- Unleashing the power of proteomics to develop blood-based cancer markers.Clinical chemistry · 2013Review
- From drug discovery to biomarker-driven clinical trials in lymphoma.Nature reviews. Clinical oncology · 2012Review
- The biology of personalized cancer medicine: facing individual complexities underlying hallmark capabilities.Molecular oncology · 2012Review
- Translating cancer 'omics' to improved outcomes.Genome research · 2012Article
Corrections and comments
- Comment on
Authors and funding
2 authors at 1 institution in 1 country.
Funding
Abstract
Taguchi et al. describe, in this issue of Cancer Cell, a quantitative comparative biomarker discovery approach that integrates animal lung cancer models with validation in well-controlled human clinical study sets. This approach overcomes many of the major barriers that have held back the field of cancer biomarkers in the past.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.